(MAR) Marriott International - Overview
Sector: Consumer Cyclical | Industry: Lodging | Exchange: NASDAQ (USA) | Market Cap: 84.143m USD | Total Return: 41.3% in 12m
Avg Trading Vol: 457M USD
Peers RS (IBD): 77.6
EPS Trend: -18.7%
Qual. Beats: 0
Rev. Trend: 83.3%
Qual. Beats: 0
Marriott International Inc. (NASDAQ: MAR) operates, franchises, and licenses a broad portfolio of hotel, residential, timeshare, and related lodging brands across North America, Europe, the Middle East & Africa, Greater China, and Asia-Pacific. Its brand suite ranges from ultra-luxury properties such as The Ritz-Carlton and St. Regis to select-service and extended-stay concepts like Courtyard, Residence Inn, and Moxy.
In the most recent quarter (Q2 2024), Marriott reported a 12% year-over-year increase in revenue per available room (RevPAR) to $176, driven by an occupancy rise to 71% and a modest ADR uplift of 4%. The company’s pipeline now includes roughly 300 new hotels slated to open over the next 24 months, adding an estimated 45,000 rooms to its global footprint.
Key macro drivers include a rebound in discretionary travel spending as inflation eases, robust leisure demand in the Asia-Pacific region, and a gradual recovery of corporate travel volumes despite higher interest rates. These factors together support Marriott’s outlook for continued top-line growth.
For deeper insight, consider reviewing the analysis on ValueRay.
- Global travel demand directly impacts occupancy rates and room pricing
- Brand expansion into new markets drives revenue growth
- Economic downturns reduce leisure and business travel spending
- Labor costs and supply chain disruptions affect operating margins
- Regulatory changes in hospitality and travel sectors create uncertainty
| Net Income: 2.60b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 2.89 > 1.0 |
| NWC/Revenue: -18.38% < 20% (prev -20.57%; Δ 2.19% < -1%) |
| CFO/TA 0.12 > 3% & CFO 3.21b > Net Income 2.60b |
| Net Debt (16.73b) to EBITDA (4.62b): 3.62 < 3 |
| Current Ratio: 0.43 > 1.5 & < 3 |
| Outstanding Shares: last quarter (269.4m) vs 12m ago -3.82% < -2% |
| Gross Margin: 21.34% > 18% (prev 0.20%; Δ 2.11k% > 0.5%) |
| Asset Turnover: 97.49% > 50% (prev 95.87%; Δ 1.62% > 0%) |
| Interest Coverage Ratio: 5.20 > 6 (EBITDA TTM 4.62b / Interest Expense TTM 809.0m) |
| A: -0.17 (Total Current Assets 3.58b - Total Current Liabilities 8.40b) / Total Assets 27.54b |
| B: 0.67 (Retained Earnings 18.41b / Total Assets 27.54b) |
| C: 0.16 (EBIT TTM 4.20b / Avg Total Assets 26.86b) |
| D: 0.57 (Book Value of Equity 17.78b / Total Liabilities 31.31b) |
| Altman-Z'' Score: 2.68 = A |
| DSRI: 1.00 (Receivables 2.91b/2.79b, Revenue 26.19b/25.10b) |
| GMI: 0.95 (GM 21.34% / 20.32%) |
| AQI: 1.00 (AQ_t 0.76 / AQ_t-1 0.76) |
| SGI: 1.04 (Revenue 26.19b / 25.10b) |
| TATA: -0.02 (NI 2.60b - CFO 3.21b) / TA 27.54b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
Over the past week, the price has changed by +2.04%, over one month by +0.90%, over three months by +6.60% and over the past year by +41.29%.
- StrongBuy: 8
- Buy: 2
- Hold: 16
- Sell: 0
- StrongSell: 1
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 356.1 | 8.9% |
| Analysts Target Price | 356.1 | 8.9% |
P/E Forward = 27.5482
P/S = 12.0514
P/B = 443.6338
P/EG = 1.9242
Revenue TTM = 26.19b USD
EBIT TTM = 4.20b USD
EBITDA TTM = 4.62b USD
Long Term Debt = 14.99b USD (from longTermDebt, last quarter)
Short Term Debt = 1.21b USD (from shortTermDebt, last quarter)
Debt = 17.08b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.73b USD (from netDebt column, last quarter)
Enterprise Value = 100.87b USD (84.14b + Debt 17.08b - CCE 358.0m)
Interest Coverage Ratio = 5.20 (Ebit TTM 4.20b / Interest Expense TTM 809.0m)
EV/FCF = 34.81x (Enterprise Value 100.87b / FCF TTM 2.90b)
FCF Yield = 2.87% (FCF TTM 2.90b / Enterprise Value 100.87b)
FCF Margin = 11.07% (FCF TTM 2.90b / Revenue TTM 26.19b)
Net Margin = 9.93% (Net Income TTM 2.60b / Revenue TTM 26.19b)
Gross Margin = 21.34% ((Revenue TTM 26.19b - Cost of Revenue TTM 20.60b) / Revenue TTM)
Gross Margin QoQ = 16.53% (prev 21.94%)
Tobins Q-Ratio = 3.66 (Enterprise Value 100.87b / Total Assets 27.54b)
Interest Expense / Debt = 1.22% (Interest Expense 208.0m / Debt 17.08b)
Taxrate = 23.54% (137.0m / 582.0m)
NOPAT = 3.21b (EBIT 4.20b * (1 - 23.54%))
Current Ratio = 0.43 (Total Current Assets 3.58b / Total Current Liabilities 8.40b)
Debt / Equity = -4.53 (negative equity) (Debt 17.08b / totalStockholderEquity, last quarter -3.77b)
Debt / EBITDA = 3.62 (Net Debt 16.73b / EBITDA 4.62b)
Debt / FCF = 5.77 (Net Debt 16.73b / FCF TTM 2.90b)
Total Stockholder Equity = -3.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.68% (Net Income 2.60b / Total Assets 27.54b)
RoE = -79.90% (negative equity) (Net Income TTM 2.60b / Total Stockholder Equity -3.26b)
RoCE = 35.80% (EBIT 4.20b / Capital Employed (Equity -3.26b + L.T.Debt 14.99b))
RoIC = 25.76% (NOPAT 3.21b / Invested Capital 12.47b)
WACC = 8.02% (E(84.14b)/V(101.23b) * Re(9.46%) + D(17.08b)/V(101.23b) * Rd(1.22%) * (1-Tc(0.24)))
Discount Rate = 9.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.53%
[DCF] Terminal Value 79.57% ; FCFF base≈2.54b ; Y1≈2.76b ; Y5≈3.47b
[DCF] Fair Price = 166.1 (EV 60.75b - Net Debt 16.73b = Equity 44.03b / Shares 265.0m; r=8.02% [WACC]; 5y FCF grow 9.96% → 3.0% )
EPS Correlation: -18.75 | EPS CAGR: -44.28% | SUE: -4.0 | # QB: 0
Revenue Correlation: 83.32 | Revenue CAGR: 13.22% | SUE: -0.35 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.06 | Chg7d=+0.004 | Chg30d=+0.028 | Revisions Net=+1 | Analysts=22
EPS current Year (2026-12-31): EPS=11.55 | Chg7d=+0.005 | Chg30d=+0.114 | Revisions Net=+2 | Growth EPS=+15.2% | Growth Revenue=+6.6%
EPS next Year (2027-12-31): EPS=12.96 | Chg7d=-0.047 | Chg30d=+0.147 | Revisions Net=+2 | Growth EPS=+12.2% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.5% (Discount Rate 9.5% - Earnings Yield 3.0%)
[Growth] Growth Spread = -0.0% (Analyst 6.5% - Implied 6.5%)